Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (393)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
50
2025
484
8.310
 Why?
Multiple Sclerosis, Relapsing-Remitting
15
2025
82
3.540
 Why?
Immunologic Factors
13
2025
258
2.400
 Why?
Neurology
10
2018
114
2.160
 Why?
Immunosuppressive Agents
10
2024
847
1.530
 Why?
Neuromyelitis Optica
4
2023
138
1.080
 Why?
Natalizumab
11
2021
41
0.900
 Why?
Recurrence
8
2025
1138
0.850
 Why?
Diagnostic Errors
2
2017
177
0.670
 Why?
Brain
16
2025
2945
0.640
 Why?
Internship and Residency
5
2011
1261
0.610
 Why?
Drug Substitution
2
2019
63
0.610
 Why?
Fingolimod Hydrochloride
5
2020
39
0.610
 Why?
Data Collection
4
2011
635
0.570
 Why?
Rituximab
4
2020
211
0.570
 Why?
Magnetic Resonance Imaging
25
2026
3888
0.570
 Why?
Dementia, Vascular
3
2009
21
0.560
 Why?
Medication Adherence
2
2019
541
0.510
 Why?
Early Medical Intervention
1
2017
61
0.500
 Why?
Early Diagnosis
2
2017
249
0.490
 Why?
Glatiramer Acetate
6
2019
18
0.480
 Why?
Calcinosis
2
2009
234
0.470
 Why?
Humans
88
2026
145305
0.470
 Why?
Drug Monitoring
1
2019
396
0.460
 Why?
Physicians
4
2016
950
0.450
 Why?
Postural Balance
3
2018
240
0.430
 Why?
Antibodies, Monoclonal, Humanized
8
2023
991
0.400
 Why?
Neuroimaging
2
2026
294
0.360
 Why?
Fatigue
3
2018
366
0.360
 Why?
Dimethyl Fumarate
3
2020
12
0.350
 Why?
Immunoglobulin G
4
2023
893
0.340
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
28
0.310
 Why?
Practice Guidelines as Topic
1
2018
1568
0.310
 Why?
Middle Aged
39
2025
36021
0.310
 Why?
Withholding Treatment
2
2021
81
0.300
 Why?
Adult
44
2026
40627
0.300
 Why?
Psychiatry
2
2009
195
0.290
 Why?
Cysts
1
2009
111
0.270
 Why?
Demyelinating Diseases
4
2019
85
0.270
 Why?
HIV Long Terminal Repeat
3
2001
11
0.270
 Why?
Education, Medical
1
2011
276
0.260
 Why?
Autoantibodies
3
2023
1510
0.260
 Why?
Lymphopenia
2
2020
65
0.250
 Why?
Certification
1
2008
121
0.250
 Why?
Education
2
2007
104
0.250
 Why?
Central Nervous System Cysts
1
2006
13
0.250
 Why?
Female
49
2025
78605
0.240
 Why?
Cerebral Arteries
1
2006
58
0.240
 Why?
Clinical Trials as Topic
3
2016
1063
0.240
 Why?
Leukoencephalopathies
1
2026
24
0.240
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
53
0.240
 Why?
Single-Blind Method
3
2023
319
0.240
 Why?
Male
40
2025
72628
0.230
 Why?
Cerebrovascular Disorders
1
2006
105
0.230
 Why?
DNA, Viral
2
1998
358
0.230
 Why?
Drug Industry
2
2016
49
0.220
 Why?
Ethics, Medical
2
2015
90
0.220
 Why?
Societies, Medical
4
2019
893
0.220
 Why?
Conflict of Interest
2
2016
53
0.220
 Why?
HIV Seropositivity
2
1998
119
0.220
 Why?
Treatment Outcome
12
2023
11731
0.210
 Why?
White Matter
1
2026
154
0.210
 Why?
Databases, Factual
3
2016
1488
0.200
 Why?
Double-Blind Method
4
2023
2033
0.200
 Why?
AIDS Dementia Complex
3
2001
52
0.200
 Why?
Microglia
2
2024
269
0.190
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
66
0.190
 Why?
Heart Aneurysm
1
2002
12
0.180
 Why?
Quality of Health Care
2
2017
696
0.170
 Why?
Heart Septal Defects, Atrial
1
2002
59
0.170
 Why?
B-Lymphocytes
5
2023
877
0.170
 Why?
Interferon beta-1a
2
2019
14
0.170
 Why?
Lymphoma
2
2005
233
0.170
 Why?
Education, Medical, Continuing
2
2015
132
0.160
 Why?
Mental Disorders
2
2007
1173
0.160
 Why?
Central Nervous System Neoplasms
2
2005
175
0.160
 Why?
Agammaglobulinemia
1
2020
36
0.160
 Why?
Brain Neoplasms
4
2016
1327
0.160
 Why?
Interferon-gamma
1
2023
784
0.150
 Why?
Serum Sickness
1
2019
4
0.150
 Why?
Indans
1
2019
13
0.150
 Why?
Oxadiazoles
1
2019
37
0.150
 Why?
Neutropenia
1
2020
155
0.150
 Why?
Disease Progression
4
2021
2855
0.150
 Why?
Diagnosis, Differential
4
2023
1500
0.150
 Why?
Referral and Consultation
1
2005
853
0.140
 Why?
Lymphoma, AIDS-Related
1
1998
14
0.140
 Why?
Adjuvants, Immunologic
3
2015
246
0.140
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
257
0.130
 Why?
Salvage Therapy
1
2019
162
0.130
 Why?
Herpesvirus 8, Human
1
1998
68
0.130
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.130
 Why?
Eye Movements
1
2018
92
0.130
 Why?
Physician-Patient Relations
2
2016
588
0.130
 Why?
Sarcoma, Kaposi
1
1998
83
0.130
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
677
0.130
 Why?
Educational Measurement
3
2015
328
0.130
 Why?
Central Nervous System
2
2005
281
0.130
 Why?
Patient Selection
2
2015
726
0.130
 Why?
Young Adult
7
2024
14163
0.120
 Why?
Herpesvirus 4, Human
1
2018
176
0.120
 Why?
Herpesviridae Infections
1
1998
150
0.120
 Why?
Nervous System Diseases
2
2024
284
0.120
 Why?
Suicide, Assisted
1
1997
31
0.120
 Why?
Neurologists
1
2016
23
0.120
 Why?
Costs and Cost Analysis
1
2017
220
0.120
 Why?
Estriol
1
2015
6
0.120
 Why?
Cost-Benefit Analysis
2
2016
639
0.120
 Why?
Aged
9
2024
26001
0.110
 Why?
Corpus Callosum
2
2006
72
0.110
 Why?
Verbal Learning
2
2013
73
0.110
 Why?
Dizziness
2
2018
101
0.110
 Why?
T-Lymphocytes
1
2023
1984
0.110
 Why?
Retrospective Studies
10
2024
17149
0.110
 Why?
Follow-Up Studies
6
2020
5431
0.100
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
154
0.100
 Why?
Trust
1
2016
155
0.100
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
59
0.100
 Why?
Medication Reconciliation
1
2013
31
0.100
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
131
0.100
 Why?
CD40 Antigens
1
2014
90
0.100
 Why?
JC Virus
1
2013
23
0.100
 Why?
Insurance, Health
1
2016
307
0.100
 Why?
Exercise Therapy
1
2018
474
0.100
 Why?
Anti-Inflammatory Agents
2
2006
475
0.100
 Why?
Stroke
1
2002
1260
0.090
 Why?
Sensation Disorders
1
2012
41
0.090
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
20
0.090
 Why?
Population Surveillance
1
2016
485
0.090
 Why?
Immunoglobulin Heavy Chains
3
2007
85
0.090
 Why?
Memory Disorders
1
2013
194
0.090
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
38
0.090
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
20
0.090
 Why?
HIV-1
2
2001
897
0.090
 Why?
Optic Nerve
2
2005
67
0.090
 Why?
T-Lymphocyte Subsets
1
2014
415
0.090
 Why?
Glioma
1
2016
427
0.080
 Why?
Gadolinium
4
2018
84
0.080
 Why?
Academies and Institutes
1
2011
60
0.080
 Why?
United States
8
2024
16051
0.080
 Why?
Self-Assessment
1
2011
74
0.080
 Why?
Nerve Regeneration
1
2010
57
0.080
 Why?
Learning
1
2015
452
0.080
 Why?
Fatal Outcome
3
2006
307
0.080
 Why?
Leukocytosis
1
2010
32
0.080
 Why?
Diagnostic Tests, Routine
1
2011
108
0.080
 Why?
Antigens, CD19
3
2007
129
0.080
 Why?
Cranial Nerve Neoplasms
1
1989
7
0.080
 Why?
Hemangioma, Cavernous
1
1989
13
0.080
 Why?
Optic Chiasm
1
1989
18
0.080
 Why?
Central Nervous System Infections
1
2010
35
0.080
 Why?
Biomarkers
3
2014
4284
0.080
 Why?
Exercise Test
1
2012
635
0.080
 Why?
Severity of Illness Index
3
2014
2926
0.070
 Why?
Quality of Life
3
2021
3197
0.070
 Why?
Disease Management
1
2013
647
0.070
 Why?
Guidelines as Topic
1
2011
268
0.070
 Why?
Spinal Cord
3
2023
383
0.070
 Why?
Neuroprotective Agents
1
2009
143
0.070
 Why?
Physical Therapy Modalities
1
2011
332
0.070
 Why?
Hospital-Physician Relations
1
2007
4
0.070
 Why?
Immunoglobulin Variable Region
2
2004
80
0.060
 Why?
Practice Patterns, Physicians'
1
2016
1358
0.060
 Why?
Workload
1
2009
170
0.060
 Why?
Vasculitis, Central Nervous System
1
2006
16
0.060
 Why?
Headache Disorders
1
2006
19
0.060
 Why?
Nerve Fibers, Myelinated
1
2006
47
0.060
 Why?
CD4-Positive T-Lymphocytes
1
1993
1130
0.060
 Why?
Neuropsychological Tests
2
2013
1138
0.060
 Why?
Methylprednisolone
1
2006
64
0.060
 Why?
Antibodies, Monoclonal
2
2011
1525
0.060
 Why?
Medical Records
1
2007
190
0.060
 Why?
Syndrome
2
2023
380
0.060
 Why?
Antibody Formation
1
2007
294
0.060
 Why?
Huntington Disease
1
2007
61
0.060
 Why?
International Classification of Diseases
1
2007
147
0.060
 Why?
Glial Fibrillary Acidic Protein
1
2006
125
0.060
 Why?
Herpes Zoster
1
2010
315
0.060
 Why?
Intracranial Hemorrhages
1
2006
100
0.060
 Why?
Contrast Media
3
2018
491
0.060
 Why?
Aquaporin 4
1
2006
99
0.060
 Why?
DNA Mutational Analysis
1
2006
409
0.060
 Why?
Adolescent
8
2024
22507
0.060
 Why?
Canada
2
2019
429
0.060
 Why?
Health Care Surveys
1
2007
539
0.060
 Why?
Analysis of Variance
3
2015
1311
0.050
 Why?
Patient Compliance
1
2009
589
0.050
 Why?
Neurologic Examination
1
2005
131
0.050
 Why?
Cognition Disorders
1
2009
538
0.050
 Why?
Fellowships and Scholarships
1
2009
357
0.050
 Why?
Teaching
1
2007
240
0.050
 Why?
RNA, Messenger
1
1992
2833
0.050
 Why?
Surveys and Questionnaires
4
2016
6079
0.050
 Why?
Program Evaluation
1
2009
949
0.050
 Why?
Central Nervous System Diseases
1
2005
74
0.050
 Why?
Colorado
2
2024
4579
0.050
 Why?
Affect
1
2007
322
0.050
 Why?
Simvastatin
1
2004
60
0.050
 Why?
Neutrophils
1
2010
1135
0.050
 Why?
Erythrocytes
1
2010
757
0.050
 Why?
Ophthalmoplegia
1
2003
13
0.050
 Why?
Proteoglycans
1
2004
110
0.050
 Why?
Prevalence
2
2024
2838
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
53
0.050
 Why?
Faculty, Medical
1
2006
303
0.050
 Why?
B-Lymphocyte Subsets
1
2003
80
0.050
 Why?
Cyclophosphamide
1
2003
267
0.050
 Why?
Radiography
1
2005
846
0.050
 Why?
Neurodegenerative Diseases
1
2024
151
0.050
 Why?
Patient Outcome Assessment
1
2023
134
0.040
 Why?
Infusions, Intravenous
1
2023
423
0.040
 Why?
Academic Medical Centers
1
2005
548
0.040
 Why?
Lymphoma, B-Cell
2
2005
134
0.040
 Why?
Students, Medical
1
2006
375
0.040
 Why?
Membrane Glycoproteins
1
2004
501
0.040
 Why?
Induced Pluripotent Stem Cells
1
2024
276
0.040
 Why?
Anticoagulants
1
2006
726
0.040
 Why?
CCAAT-Enhancer-Binding Proteins
1
2001
38
0.040
 Why?
Pain
1
2007
784
0.040
 Why?
Molecular Sequence Data
3
2004
2931
0.040
 Why?
Disability Evaluation
2
2014
310
0.040
 Why?
Single-Cell Analysis
1
2024
359
0.040
 Why?
Antibodies, Antinuclear
1
2001
62
0.040
 Why?
Peptides
3
2013
999
0.040
 Why?
Schools, Medical
1
2002
157
0.040
 Why?
Cross-Sectional Studies
1
2012
5883
0.040
 Why?
Atrophy
1
2021
201
0.040
 Why?
Dementia
1
2005
304
0.040
 Why?
Time Factors
4
2018
7186
0.040
 Why?
Proteasome Endopeptidase Complex
1
2001
159
0.040
 Why?
Mobility Limitation
1
2020
66
0.040
 Why?
Clinical Competence
1
2008
1247
0.040
 Why?
Venous Thrombosis
1
2002
195
0.040
 Why?
Child
5
2016
22712
0.040
 Why?
Interferon-beta
2
2011
92
0.040
 Why?
Lymphocyte Activation
1
2003
1127
0.040
 Why?
Antibodies, Viral
1
2023
673
0.040
 Why?
Maintenance Chemotherapy
1
2019
42
0.040
 Why?
Cell Separation
2
2014
307
0.040
 Why?
Cerebral Infarction
1
1998
47
0.040
 Why?
Induction Chemotherapy
1
2019
87
0.030
 Why?
Lipids
1
2023
712
0.030
 Why?
HIV Seronegativity
1
1998
29
0.030
 Why?
Genes, myc
1
1998
51
0.030
 Why?
Base Sequence
2
2001
2191
0.030
 Why?
Transplantation, Autologous
1
2019
292
0.030
 Why?
Astrocytoma
1
1998
129
0.030
 Why?
In Situ Hybridization
1
2018
319
0.030
 Why?
Gene Library
1
1997
126
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2018
341
0.030
 Why?
Gene Rearrangement
1
1998
155
0.030
 Why?
Risk Assessment
1
2006
3686
0.030
 Why?
Managed Care Programs
1
1997
140
0.030
 Why?
Syndecan-1
2
2007
43
0.030
 Why?
Drug Administration Schedule
1
2018
783
0.030
 Why?
Morals
1
1997
79
0.030
 Why?
Flow Cytometry
2
2014
1173
0.030
 Why?
Breast Neoplasms
1
2008
2464
0.030
 Why?
Risk Factors
3
2008
10816
0.030
 Why?
Viral Load
1
2018
527
0.030
 Why?
Mutation
1
2006
4104
0.030
 Why?
Polymerase Chain Reaction
1
1998
1054
0.030
 Why?
Survival Analysis
1
2018
1386
0.030
 Why?
Sequence Analysis, DNA
1
1997
824
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1420
0.030
 Why?
Child, Preschool
3
2016
11863
0.020
 Why?
Incidence
1
2020
2892
0.020
 Why?
Congresses as Topic
1
2015
221
0.020
 Why?
Propylene Glycols
1
2013
27
0.020
 Why?
Ocular Physiological Phenomena
1
1992
10
0.020
 Why?
HLA-DR Antigens
1
2014
220
0.020
 Why?
Patient Care Team
1
2019
692
0.020
 Why?
Sphingosine
1
2013
45
0.020
 Why?
beta-Galactosidase
1
1992
77
0.020
 Why?
Quality-Adjusted Life Years
1
2013
122
0.020
 Why?
Drug Therapy, Combination
1
2015
1048
0.020
 Why?
Markov Chains
1
2013
130
0.020
 Why?
Leukocyte Count
1
1993
316
0.020
 Why?
Mice, Inbred DBA
1
1992
187
0.020
 Why?
Haplotypes
1
2014
490
0.020
 Why?
Organ Specificity
1
1992
313
0.020
 Why?
Reference Values
1
2013
798
0.020
 Why?
Comparative Effectiveness Research
1
2013
170
0.020
 Why?
CD3 Complex
1
2012
111
0.020
 Why?
Ki-67 Antigen
1
2012
117
0.020
 Why?
Thymus Gland
1
1992
311
0.020
 Why?
Mental Recall
1
2013
222
0.020
 Why?
Intestine, Small
1
1992
166
0.020
 Why?
Mitoxantrone
1
2011
15
0.020
 Why?
Hematologic Tests
1
2011
21
0.020
 Why?
Mice
2
2023
18394
0.020
 Why?
Muscle Stretching Exercises
1
2011
19
0.020
 Why?
Animals
3
2023
38177
0.020
 Why?
Patient Participation
1
2015
433
0.020
 Why?
Clinical Laboratory Techniques
1
2011
96
0.020
 Why?
Depression
2
2011
1561
0.020
 Why?
Recombinant Fusion Proteins
1
1992
675
0.020
 Why?
Amino Acid Sequence
2
2004
2158
0.020
 Why?
Physical Endurance
1
2011
278
0.020
 Why?
Acyclovir
1
2010
96
0.020
 Why?
Spinal Cord Neoplasms
1
1989
41
0.020
 Why?
Cell Count
1
2010
321
0.020
 Why?
Respiratory Function Tests
1
2011
547
0.020
 Why?
History, 19th Century
1
2009
62
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1747
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
58
0.020
 Why?
Aged, 80 and over
2
2016
8295
0.020
 Why?
Injections
1
2009
197
0.020
 Why?
History, 21st Century
1
2009
220
0.020
 Why?
Pilot Projects
2
2004
1894
0.020
 Why?
Autoimmunity
1
2014
935
0.020
 Why?
History, 20th Century
1
2009
327
0.020
 Why?
Electrocardiography
1
2011
663
0.020
 Why?
Gene Expression
1
1992
1490
0.020
 Why?
Mice, Transgenic
1
1992
2192
0.020
 Why?
Health
1
2007
81
0.020
 Why?
Age of Onset
1
2009
551
0.020
 Why?
Memory
1
2009
296
0.020
 Why?
Association Learning
1
2007
71
0.020
 Why?
Walking
1
2011
545
0.020
 Why?
Herpesvirus 3, Human
1
2010
336
0.010
 Why?
Cerebral Ventricles
1
2006
54
0.010
 Why?
CD8-Positive T-Lymphocytes
1
2012
918
0.010
 Why?
Prognosis
2
2006
4310
0.010
 Why?
Motor Skills
1
2007
104
0.010
 Why?
Phenotype
1
2014
3172
0.010
 Why?
Genetics
1
2005
23
0.010
 Why?
Models, Theoretical
1
2009
582
0.010
 Why?
Hypothalamus
1
2006
160
0.010
 Why?
Immunologic Memory
1
2007
366
0.010
 Why?
Neurosciences
1
2005
25
0.010
 Why?
Syndecans
1
2004
5
0.010
 Why?
Social Support
1
2009
652
0.010
 Why?
Anisotropy
1
2004
75
0.010
 Why?
Hospitalization
1
2015
2443
0.010
 Why?
Clinical Protocols
1
2006
282
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
286
0.010
 Why?
Immune System
1
2005
179
0.010
 Why?
Internet
1
2009
701
0.010
 Why?
Plasma Cells
1
2004
79
0.010
 Why?
Antiviral Agents
1
2010
768
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
11
0.010
 Why?
Meningitis, Viral
1
2003
20
0.010
 Why?
Infrared Rays
1
2003
27
0.010
 Why?
Videotape Recording
1
2003
37
0.010
 Why?
Saccades
1
2003
45
0.010
 Why?
Antilymphocyte Serum
1
2003
61
0.010
 Why?
Oligoclonal Bands
1
2003
26
0.010
 Why?
Antigens, CD34
1
2003
88
0.010
 Why?
Clone Cells
1
2003
266
0.010
 Why?
Whole-Body Irradiation
1
2003
76
0.010
 Why?
Astrocytes
1
2005
225
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
134
0.010
 Why?
Immunoglobulins
1
2003
160
0.010
 Why?
Observer Variation
1
2003
355
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
192
0.010
 Why?
Feasibility Studies
1
2006
1103
0.010
 Why?
ATPases Associated with Diverse Cellular Activities
1
2001
9
0.010
 Why?
Mice, Inbred C57BL
1
1992
6007
0.010
 Why?
Administration, Oral
1
2004
848
0.010
 Why?
Age Factors
1
2009
3339
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2745
0.010
 Why?
Consensus Sequence
1
2001
74
0.010
 Why?
Biopsy
1
2005
1079
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
983
0.010
 Why?
Longitudinal Studies
1
2009
2959
0.010
 Why?
Sex Characteristics
1
2007
791
0.010
 Why?
Cytomegalovirus Infections
1
2003
206
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
23
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
56
0.010
 Why?
Gene Expression Regulation, Viral
1
2001
94
0.010
 Why?
Urinary Tract Infections
1
2003
206
0.010
 Why?
Infant
1
2015
10101
0.010
 Why?
Cohort Studies
1
2011
5982
0.010
 Why?
Predictive Value of Tests
1
2006
2118
0.010
 Why?
Acute Disease
1
2003
1031
0.010
 Why?
Research
1
2003
431
0.010
 Why?
Combined Modality Therapy
1
2003
1268
0.010
 Why?
Lung
1
1992
4112
0.010
 Why?
Arachnoid
1
1998
11
0.010
 Why?
Sensitivity and Specificity
1
2003
1992
0.010
 Why?
Monocytes
1
2001
538
0.010
 Why?
Survival Rate
1
2003
2100
0.010
 Why?
Virus Replication
1
2001
529
0.010
 Why?
Binding Sites
1
2001
1333
0.010
 Why?
Models, Biological
1
2005
1823
0.010
 Why?
Case-Control Studies
1
2004
3613
0.010
 Why?
Aging
1
2007
1968
0.010
 Why?
Reproducibility of Results
1
2003
3419
0.010
 Why?
Transcription, Genetic
1
2001
1496
0.010
 Why?
DNA-Binding Proteins
1
2001
1503
0.010
 Why?
Cells, Cultured
1
2001
4155
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (393) concept(s)
_
Co-Authors Expand Description
See all (38) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)